Literature DB >> 9605103

Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method.

G Molino1, P Avagnina, G Belforte, J Bircher.   

Abstract

D-Sorbitol (SOR) is safe, is easy to measure, and has an exceptionally high extraction ratio in the normal liver of 0.93+/-0.05 (mean+/-SD). Together with the general interest in hepatic hemodynamics, these facts motivated us to review the usefulness of this compound for the assessment of liver plasma flow in humans. We concluded that in subjects without liver disease the nonrenal clearance of SOR-measured noninvasively-very closely approximates hepatic plasma flow. Because of its lower and more variable extraction ratio, indocyanine green should no longer be used without hepatic vein catheterization. Even in patients with cirrhosis, SOR exhibits higher hepatic extraction ratios than indocyanine green. To fully explore the potential of SOR in the evaluation of such patients attention needs to be paid to the complex changes in architecture and function occurring in this disease. In cirrhotics the noninvasively measured nonrenal clearance of SOR presumably approximates the flow through intact and capillarized sinusoids (functional flow) and reflects the amount of blood having functional contact with hepatocytes. The theoretic background of the method, its accuracy, further research needs, and potentials of various approaches are discussed in detail.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605103     DOI: 10.1016/s0022-2143(98)90139-1

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

Review 1.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.

Authors:  Mai-Lin Chen; Qing-Yu Zeng; Jian-Wei Huo; Xiao-Ming Yin; Bao-Ping Li; Jian-Xin Liu
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

3.  A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-03-24       Impact factor: 7.527

4.  Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations.

Authors:  E Garello; S Battista; F Bar; G A Niro; N Cappello; M Rizzetto; G Molino
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

5.  Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?

Authors:  P Ott; O Clemmesen; S Keiding
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

6.  Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers.

Authors:  Eleonora L Swart; Ben van der Hoven; A B Johan Groeneveld; Daniel J Touw; Meindert Danhof
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

7.  Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.

Authors:  Yi-Ming Li; Fan Lv; Xin Xu; Hong Ji; Wen-Tao Gao; Tuan-Jie Lei; Gui-Bing Ren; Zhi-Lan Bai; Qiang Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Location and function of intrahepatic shunts in anaesthetised rats.

Authors:  X Li; I S Benjamin; R Naftalin; B Alexander
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 9.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

10.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.